tickerreport.com
Positivewww.tickerreport.com Β·
matthew shawn morris sells 1017 shares of privia health group nasdaqprva stock
TAX_FNCACT_PHYSICIANTAX_FNCACT_ANALYSTSTAX_FNCACT_ANALYSTTAX_FNCACT_INSIDER
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedInsider sale of 1,017 shares by a director under a pre-arranged plan; no direct commercial mechanism beyond routine insider trading. The company's earnings beat is a positive signal but the sale is not driven by operational changes. Impact is company-specific and weak.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources β not direct quotes from the publisher.
- Matthew Shawn Morris sold 1,017 shares of Privia Health Group (PRVA) on May 4, 2026 at $24.96.
- The sale was part of a pre-arranged Rule 10b5-1 trading plan.
- Privia Health reported quarterly earnings of $0.19 per share, exceeding expectations, with revenues of $603.85 million.